From: Study of HOTAIR LncRNA in AML patients in context to FLT3-ITD and NPM1 mutations status
CR | Outcome | |||
---|---|---|---|---|
CR | % | Poor | % | |
Low expression | ||||
NPM1-WT/FLT3WT | 4/9 | 44% | 7/9 | 89% |
NPM1-mut/FLT3-mut | 2/2 | 100% | 2/2 | 100 |
NPM1-mut/FLT3-WT | 1/5 | 20% | 5/5 | 100% |
NPM1-WT/FLT3-mut | 1/6 | 16% | 5/6 | 84% |
High expression | ||||
NPM1-WT/FLT3-WT | 4/13 | 38% | 10/13 | 62% |
NPM1-mut/FLT3-mut | 1/3 | 33% | 3/3 | 100% |
NPM1-WT/FLT-mut | 5/8 | 63% | 3/8 | 37.5 |